The DZL was represented with an information desk at the 60th Congress of the German Respiratory Society (DGP), which took place in Munich from March 13–16, 2019.
Studying the lung microbiome requires a specialist approach to sampling, laboratory techniques and statistical analysis.
Around 500 scientists, physicians, and junior researchers from five sites attended the 8th DZL Annual Meeting on February 7 and 8 at the Rosengarten Mannheim.
The new technology can be used to understand the therapeutic success of inhaled active substances.
The German Center for Lung Research (DZL), one of the six German Centers for Health Research (DZG), follows the current discussion on the health risk posed by air pollutants with great concern.
Meaningful data on genetic alterations in tumors provide the basis for successful targeted therapy.
Pulmonary Hypertension (PH) is a severe condition of the lungs and the heart, which cannot be cured.
The cohort study COSYCONET investigates how lung health, comorbidities, and systemic inflammation are related in patients with Chronic Obstructive Pulmonary Disease (COPD).
With over 10 million new tuberculosis (TB) cases and 1.6 million deaths, TB is a global health priority. Multidrug-resistant TB is of particular concern to both clinicians and national TB programmes.
Scientists at Helmholtz Zentrum München, member of the DZL, have now reported a previously unknown pathogenic mechanism..
Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall.
Marcus Mall is now medical director of the…
